Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 290531, 13 pages
http://dx.doi.org/10.1155/2014/290531
Review Article

Common Polymorphism in the LRP5 Gene May Increase the Risk of Bone Fracture and Osteoporosis

Department of Orthopaedics, Drum Tower Hospital, Medical School of Nanjing University, Zhongshan Road No. 321, Nanjing 210008, China

Received 14 June 2014; Revised 10 September 2014; Accepted 10 September 2014; Published 14 December 2014

Academic Editor: Mohammad I. Kamboh

Copyright © 2014 Guang-Yue Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X.-F. Wang and E. Seeman, “Epidemiology and structural basis of racial differences in fragility fractures in Chinese and Caucasians,” Osteoporosis International, vol. 23, no. 2, pp. 411–422, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. J. C. Pressley, T. D. Kendig, S. K. Frencher, B. Barlow, L. Quitel, and F. Waqar, “Epidemiology of bone fracture across the age span in blacks and whites,” The Journal of trauma, vol. 71, supplement 2, no. 5, pp. S541–S548, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Banu, “Causes, consequences, and treatment of osteoporosis in men,” Drug Design, Development and Therapy, vol. 7, pp. 849–860, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Ofotokun and M. N. Weitzmann, “HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 17, no. 6, pp. 523–529, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J.-E. Kim, M.-H. Hsieh, B. K. Soni, M. Zayzafoon, and D. B. Allison, “Childhood obesity as a risk factor for bone fracture: a mechanistic study,” Obesity, vol. 21, no. 7, pp. 1459–1466, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Hadji, S. Klein, H. Gothe et al., “The epidemiology of osteoporosis—Bone Evaluation Study (BEST): an analysis of routine health insurance data,” Deutsches Ärzteblatt International, vol. 110, no. 4, pp. 52–57, 2013. View at Google Scholar
  7. E. M. Lewiecki, J. P. Bilezikian, L. Bonewald et al., “Osteoporosis update: proceedings of the 2013 santa fe bone symposium,” Journal of Clinical Densitometry, vol. 17, no. 3, pp. 330–343, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Raje, C. Botre, and R. Ashma, “Genetic epidemiology of osteoporosis across four microsatellite markers near the VDR gene,” International Journal of Molecular Epidemiology and Genetics, vol. 4, no. 2, pp. 101–108, 2013. View at Google Scholar · View at Scopus
  9. A. Lehouck, S. Boonen, M. Decramer, and W. Janssens, “COPD, bone metabolism, and osteoporosis,” Chest, vol. 139, no. 3, pp. 648–657, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. N. M. Cummins, E. K. Poku, M. R. Towler, O. M. O'Driscoll, and S. H. Ralston, “Clinical risk factors for osteoporosis in Ireland and the UK: a comparison of FRAX and QFractureScores,” Calcified Tissue International, vol. 89, no. 2, pp. 172–177, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Kruk, S. H. Ralston, and O. M. E. Albagha, “LRP5 polymorphisms and response to risedronate treatment in osteoporotic men,” Calcified Tissue International, vol. 84, no. 3, pp. 171–179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Saarinen, T. Saukkonen, T. Kivelä et al., “Low density lipoprotein receptor-related protein 5 (LRP5) mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemia,” Clinical Endocrinology, vol. 72, no. 4, pp. 481–488, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Marques-Pinheiro, R. Levasseur, C. Cormier et al., “Novel LRP5 gene mutation in a patient with osteoporosis-pseudoglioma syndrome,” Joint Bone Spine, vol. 77, no. 2, pp. 151–153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. B. J. van Meurs, T. A. Trikalinos, S. H. Ralston et al., “Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis,” Journal of the American Medical Association, vol. 299, no. 11, pp. 1277–1290, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. J. P. Smith, J. Gidley, J. R. Sandy et al., “Haplotypes of the low-density lipoprotein receptor-related protein 5 (LRP5) gene: are they a risk factor in osteoarthritis?” Osteoarthritis and Cartilage, vol. 13, no. 7, pp. 608–613, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Furuya, T. Urano, K. Ikari et al., “A1330V polymorphism of low-density lipoprotein receptor-related protein 5 gene and self-reported incident fractures in Japanese female patients with rheumatoid arthritis,” Modern Rheumatology, vol. 19, no. 2, pp. 140–146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Agueda, R. Velázquez-Cruz, R. Urreizti et al., “Functional relevance of the BMD-associated polymorphism rs312009: novel involvement of RUNX2 in LRP5 transcriptional regulation,” Journal of Bone and Mineral Research, vol. 26, no. 5, pp. 1133–1144, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. C. M. Laine, B. D. Chung, M. Susic et al., “Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG),” European Journal of Human Genetics, vol. 19, no. 8, pp. 875–881, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Goltzman, “LRP5, serotonin, and bone: complexity, contradictions, and conundrums,” Journal of Bone and Mineral Research, vol. 26, no. 9, pp. 1997–2001, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. B. N. H. Tran, N. D. Nguyen, J. A. Eisman, and T. V. Nguyen, “Association between LRP5 polymorphism and bone mineral density: a Bayesian meta-analysis,” BMC Medical Genetics, vol. 9, article 55, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Funakoshi, H. Omori, H. Yada, and T. Katoh, “Relationship between changes of bone mineral density over seven years and A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene or lifestyle factors in Japanese female workers,” Asia Pacific Journal of Clinical Nutrition, vol. 19, no. 4, pp. 534–539, 2010. View at Google Scholar · View at Scopus
  22. E. Falcón-Ramírez, L. Casas-Avila, R. M. Cerda-Flores et al., “Association of LRP5 haplotypes with osteoporosis in Mexican women,” Molecular Biology Reports, vol. 40, no. 3, pp. 2705–2710, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. H. K. Genant, C. Cooper, G. Poor et al., “Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis,” Osteoporosis International, vol. 10, no. 4, pp. 259–264, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Nakamura, “Absolute risk for fracture and WHO guideline: fracture risk assessments recommended by World Health Organization and Japanese guidelines for prevention and treatment of osteoporosis 2006,” Clinical calcium, vol. 17, no. 7, pp. 1022–1028, 2007. View at Google Scholar · View at Scopus
  25. A. Stang, “Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses,” European Journal of Epidemiology, vol. 25, no. 9, pp. 603–605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Zintzaras and J. P. A. Ioannidis, “HEGESMA: genome search meta-analysis and heterogeneity testing,” Bioinformatics, vol. 21, no. 18, pp. 3672–3673, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Zintzaras and J. P. A. Ioannidis, “Heterogeneity testing in meta-analysis of genome searches,” Genetic Epidemiology, vol. 28, no. 2, pp. 123–137, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. J. P. Higgins and S. G. Thompson, “Quantifying heterogeneity in a meta-analysis,” Statistics in Medicine, vol. 21, no. 11, pp. 1539–1558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Song and S. Gilbody, “Bias in meta-analysis detected by a simple, graphical test: increase in studies of publication bias coincided with increasing use of meta-analysis,” British Medical Journal, vol. 316, no. 7129, p. 471, 1998. View at Google Scholar · View at Scopus
  30. J. L. Peters, A. J. Sutton, D. R. Jones, K. R. Abrams, and L. Rushton, “Comparison of two methods to detect publication bias in meta-analysis,” Journal of the American Medical Association, vol. 295, no. 6, pp. 676–680, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. S. L. Ferrari, S. Deutsch, C. Baudoin et al., “LRP5 gene polymorphisms and idiopathic osteoporosis in men,” Bone, vol. 37, no. 6, pp. 770–775, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Mizuguchi, I. Furuta, Y. Watanabe et al., “LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density,” Journal of Human Genetics, vol. 49, no. 2, pp. 80–86, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Xuan, Y. Wang, W. Wang, J. Yang, Y. Li, and X. Zhang, “Association of LRP5 gene polymorphism with type 2 diabetes mellitus and osteoporosis in postmenopausal women,” International Journal of Clinical and Experimental Medicine, vol. 7, no. 1, pp. 247–254, 2014. View at Google Scholar · View at Scopus
  34. J. M. Liu, M. J. Zhang, L. Zhao et al., “Analysis of recently identified osteoporosis susceptibility genes in Han Chinese women,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 9, pp. E112–E120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Hartikka, O. Mäkitie, M. Männikkö et al., “Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children,” Journal of Bone and Mineral Research, vol. 20, no. 5, pp. 783–789, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. D. K. Strickland, S. L. Gonias, and W. S. Argraves, “Diverse roles for the LDL receptor family,” Trends in Endocrinology and Metabolism, vol. 13, no. 2, pp. 66–74, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. M. A. Koay and M. A. Brown, “Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton,” Trends in Molecular Medicine, vol. 11, no. 3, pp. 129–137, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Gong, R. B. Slee, N. Fukai et al., “LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development,” Cell, vol. 107, no. 4, pp. 513–523, 2001. View at Google Scholar
  39. J. Bollerslev, S. G. Wilson, I. M. Dick et al., “LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women,” Bone, vol. 36, no. 4, pp. 599–606, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Korvala, H. Jüppner, O. Mäkitie et al., “Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity,” BMC Medical Genetics, vol. 13, article 26, 2012. View at Publisher · View at Google Scholar · View at Scopus